Adenovirus infection in children after allogeneic stem cell transplantation: Diagnosis, treatment and immunity

Bone Marrow Transplantation

Volumn 35, Issue , 2005, Pages S73-S76

  Van Tol, M J D ^a   Claas, E C J ^a   Heemskerk, B ^a   Veltrop Duits, L A ^a   de Brouwer, C S ^a   van Vreeswijk, T ^a   Sombroek, C C ^a   Kroes, A C M ^a   Beersma, M F C ^a   De Klerk, E P A ^a   Egeler, R M ^a   Lankester, A C ^a   Schilham, M W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adenovirus infection; Allogeneic SCT; Children; Diagnosis; Immunity; Treatment

Indexed keywords

ALEMTUZUMAB; CIDOFOVIR; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MELPHALAN; RIBAVIRIN; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL TRIAL; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENTIATION; FATALITY; GRAFT FAILURE; GRAFT REJECTION; HIGH RISK PATIENT; HUMAN; HUMAN ADENOVIRUS; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; LONG TERM CARE; NEPHROTOXICITY; PATHOGENESIS; PATIENT MONITORING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS LOAD;

ADENOVIRUS INFECTIONS, HUMAN; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 20944451095     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704852     Document Type: Article

References (27)

1. Walls T, Shankar AG, Shingadia D. Adenovirus: an increasingly important pathogen in paediatric bone marrowtransplant patients. Lancet Infect Dis 2003; 3: 79-86.
2. Kojaoghlanian T, Flomenberg P, Horwitz MS. The impact of adenovirus infection on the immunocompromised host. Rev Med Virol 2003; 13: 155-171.
3. Horwitz MS. Adenoviruses. In: Knipe DM, Howley PM (eds). Fields' Virology. Lippincott Williams & Wilkins: Philadelphia, 2001, pp 2301-2326.
4. Garnett CT, Erdman D, Xu W, Gooding LR. Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J Virol 2002; 76: 10608-10616.
5. Heemskerk B, Lankester AC, van Vreeswijk T et al. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. J Infect Dis 2005; 191, in press.
6. Lankester AC, van Tol MJD, Claas ECJ et al. Quantification of adenovirus DNA in plasma: a role in management of stem cell graft recipients. Clin Infect Dis 2002; 34: 864-867.
7. Schilham MW, Claas EC, van Zaane W et al. High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation. Clin Infect Dis 2002; 35: 526-532.
8. Lion T, Baumgartinger R, Watzinger F et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrowtransplantation permits early diagnosis of disseminated disease. Blood 2003; 102: 1114-1120.
9. Bordigoni P, Carret AS, Venard V et al. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2001; 32: 1290-1297.
10. Legrand F, Berrebi D, Houhou N et al. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrowtransplantation in children. Bone Marrow Transplant 2001; 27: 621-626.
11. Hoffman JA, Shah AJ, Ross LA, Kapoor N. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 388-394.
12. Miyamura K, Hamaguchi M, Taji H et al. Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrowtransplant from close HLA donors rather than distant donors. Bone Marrow Transplant 2000; 25: 545-548.
13. Lankester AC, Heemskerk B, Claas EC et al. Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. Clin Infect Dis 2004; 38: 1521-1525.
14. Schleuning M, Buxbaum-Conradi H, Jager G, Kolb HJ. Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants. Hematol J 2004; 5: 135-144.
15. Morfin F, Dupuis-Girod S, Mundweiler S et al. In vitro susceptibility of adenovirus to antiviral drugs is speciesdependent. Antiviral Ther 2005, in press.
16. Olive M, Eisenlohr L, Flomenberg N et al. The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope. Hum Gene Ther 2002; 13: 1167-1178.
17. Leen AM, Sili U, Vanin EF et al. Conserved CTL epitopes on the adenovirus hexon protein expand subgroup crossreactive and subgroup-specific CD8+ T cells. Blood 2004; 104: 2432-2440.
18. Burgert HG, Ruzsics Z, Obermeier S et al. Subversion of host defense mechanisms by adenoviruses. Curr Top Microbiol Immunol 2002; 269: 273-318.
19. Hromas R, Cornetta K, Srour E et al. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T cell depleted bone marrowtranspl antation. Blood 1994; 84: 1689-1690.
20. Chakrabarti S, Collingham KE, Fegan CD et al. Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy? Bone Marrow Transplant 2000; 26: 305-307.
21. Chakrabarti S, Mautner V, Osman H et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 2002; 100: 1619-1627.
22. Andre-Schmutz I, Le Deist F, Hacein-Bey-Abina S et al. Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study. Lancet 2002; 360: 130-137.
23. Heemskerk B, Veltrop-Duits LA, van Vreeswijk T et al. Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy. J Virol 2003; 77: 6562-6566.
24. Veltrop-Duits LA, Heemskerk B, Sombroek CC et al. Human CD4+ T cells preferentially recognize conserved peptides of the adenovirus hexon protein: consequences for immuno-and gene therapy (submitted).
25. Regn S, Raffegerst S, Chen X et al. Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrowtransplant. Bone Marrow Transplant 2001; 27: 53-64.
26. Leen AM, Sili U, Savoldo B et al. Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications. Blood 2004; 103: 1011-1019.
27. Feuchtinger T, Lang P, Hamprecht K et al. Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy. Exp Hematol 2004; 32: 282-289.